DK1267831T3 - Hidtil ukendt selvemulgerende system til lægemiddelindgift - Google Patents

Hidtil ukendt selvemulgerende system til lægemiddelindgift

Info

Publication number: DK1267831T3
Authority: DK; Denmark
Prior art keywords: drug administration; emulsifying system; hitherto unknown; optionally; unknown self
Prior art date: 2000-03-08

Application number

DK01910304T

Other languages

English (en)

Inventor

Christina Holmberg

Britta Siekmann

Original Assignee

Nicox Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-08

Filing date

2001-03-06

Publication date

2006-03-20

2001-03-06 Application filed by Nicox Sa filed Critical Nicox Sa

2006-03-20 Application granted granted Critical

2006-03-20 Publication of DK1267831T3 publication Critical patent/DK1267831T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK01910304T 2000-03-08 2001-03-06 Hidtil ukendt selvemulgerende system til lægemiddelindgift DK1267831T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0000774A SE0000774D0 (sv)	2000-03-08	2000-03-08	New formulation

Publications (1)

Publication Number	Publication Date
DK1267831T3 true DK1267831T3 (da)	2006-03-20

Family

ID=20278740

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01910304T DK1267831T3 (da)	2000-03-08	2001-03-06	Hidtil ukendt selvemulgerende system til lægemiddelindgift

Country Status (28)

Country	Link
US (2)	US7736666B2 (da)
EP (1)	EP1267831B1 (da)
JP (1)	JP4656479B2 (da)
KR (1)	KR100771318B1 (da)
CN (1)	CN1283229C (da)
AR (1)	AR027554A1 (da)
AT (1)	ATE311173T1 (da)
AU (2)	AU2001237875B2 (da)
BR (1)	BR0109012B1 (da)
CA (1)	CA2401857A1 (da)
CZ (1)	CZ303524B6 (da)
DE (1)	DE60115402T2 (da)
DK (1)	DK1267831T3 (da)
EE (1)	EE200200483A (da)
ES (1)	ES2253354T3 (da)
HU (1)	HU229103B1 (da)
IL (1)	IL151380A0 (da)
IS (1)	IS6538A (da)
MX (1)	MXPA02008658A (da)
MY (1)	MY137749A (da)
NO (1)	NO331921B1 (da)
RU (1)	RU2275908C2 (da)
SE (1)	SE0000774D0 (da)
SI (1)	SI1267831T1 (da)
SK (1)	SK285749B6 (da)
UA (1)	UA76098C2 (da)
WO (1)	WO2001066087A1 (da)
ZA (1)	ZA200207109B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9600070D0 (sv)	1996-01-08	1996-01-08	Astra Ab	New oral pharmaceutical dosage forms
SE0000773D0 (sv) *	2000-03-08	2000-03-08	Astrazeneca Ab	New formulation
IT1319202B1 (it)	2000-10-12	2003-09-26	Nicox Sa	Farmaci per le malattie a base infiammatoria.
SE0102993D0 (sv) *	2001-09-07	2001-09-07	Astrazeneca Ab	New self emulsifying drug delivery system
ITMI20021392A1 (it) *	2002-06-25	2003-12-29	Nicox Sa	Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
AU2003900887A0 (en) *	2003-02-27	2003-03-13	Novasel Australia Pty Ltd	Poloxamer emulsion preparations
US8802116B2 (en)	2003-02-27	2014-08-12	Novasel Australia Pty. Ltd.	Poloxamer emulsion preparations
DE10353937A1 (de) *	2003-11-18	2005-06-30	Fresenius Medical Care Deutschland Gmbh	Vorrichtung zur Übertragung einer Referenzflüssigkeit in ein Messgerät, Messgerät mit einer solchen Vorrichtung und Verfahren zur Übertragung einer Referenzflüssigkeit in ein Messgerät
GB0402679D0 (en) *	2004-02-06	2004-03-10	Novartis Ag	Organic compounds
EP1750729A2 (en) *	2004-05-06	2007-02-14	Emisphere Technologies, Inc.	Solid dosage form of wetted heparin
CA2565188C (en)	2004-05-14	2014-03-04	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
KR100654617B1 (ko) *	2004-09-23	2006-12-08	정해현	스틱이 내장된 커피믹스 팩과 커피믹스 박스
ATE485033T1 (de) *	2005-07-26	2010-11-15	Nicox Sa	Pharmazeutische formulierung von nitrooxy- derivaten von nsar
CN103190631B (zh)	2008-03-20	2016-01-20	维尔恩公司	非水性预乳液组合物及制备包含植物甾醇的饮料的方法
AU2009226019C1 (en)	2008-03-20	2014-02-20	Virun, Inc.	Emulsions including a PEG-derivative of tocopherol
JP5951489B2 (ja)	2009-10-16	2016-07-13	グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅＬＬＣ	組成物
WO2011162802A1 (en)	2010-06-21	2011-12-29	Virun, Inc.	Compositions containing non-polar compounds
US9968557B1 (en)	2011-02-09	2018-05-15	Florida A&M University	Method of preparing modified multilayered microstructures with enhanced oral bioavailability
KR20240076240A (ko) *	2022-11-23	2024-05-30	(주) 바이오인프라생명과학	더블 에멀젼 구조의 초음파 감응형 약물전달체를 생성하는 방법
WO2025219169A1 (en)	2024-04-16	2025-10-23	Bayer Consumer Care Ag	Stable soft capsule preparations with liquid fill for moisture sensitive active ingredients

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7804231L (sv) *	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
CY1398A (en)	1981-09-04	1987-12-18	Glaxo Group Ltd	Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
JPS59227870A (ja) *	1983-06-07	1984-12-21	Yamanouchi Pharmaceut Co Ltd	新規２−グアニジノチアゾリン誘導体ならびにその製造法
US4554276A (en)	1983-10-03	1985-11-19	Pfizer Inc.	2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4522826A (en)	1984-02-08	1985-06-11	Richardson-Vicks Inc.	Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4552899A (en) *	1984-04-09	1985-11-12	Analgesic Associates	Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
IL75400A (en)	1984-06-16	1988-10-31	Byk Gulden Lomberg Chem Fab	Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja)	1984-08-16	1986-03-13	Takeda Chem Ind Ltd	ピリジン誘導体およびその製造法
AU4640985A (en)	1984-08-31	1986-03-06	Nippon Chemiphar Co. Ltd.	Benzimidazole derivatives
US4766117A (en)	1984-10-11	1988-08-23	Pfizer Inc.	Antiinflammatory compositions and methods
US4676984A (en)	1985-08-14	1987-06-30	American Home Products Corp.	Rehydratable antacid composition
US4704278A (en)	1984-10-17	1987-11-03	American Home Products Corp (Del)	Fluidized magaldrate suspension
US5037815A (en)	1986-03-04	1991-08-06	Bristol-Myers Squibb Co.	Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers
US5043358A (en) *	1986-03-04	1991-08-27	Bristol-Myers Squibb Company	Gastroprotective process
US4757060A (en)	1986-03-04	1988-07-12	Bristol-Myers Company	Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
US4965065A (en) *	1986-04-29	1990-10-23	Bristol-Myers Squibb Company	Gastroprotective process and compositions
GB2189698A (en)	1986-04-30	1987-11-04	Haessle Ab	Coated omeprazole tablets
US5260333A (en) *	1986-08-08	1993-11-09	Bristol Myers Squibb Company	Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
GB8630273D0 (en)	1986-12-18	1987-01-28	Til Medical Ltd	Pharmaceutical delivery systems
EP0320550A1 (en)	1987-12-18	1989-06-21	Bristol-Myers Company	Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent
SE8804629D0 (sv)	1988-12-22	1988-12-22	Ab Haessle	New therapeutically active compounds
NZ235877A (en)	1989-11-02	1992-09-25	Mcneil Ppc Inc	Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
US5204118A (en)	1989-11-02	1993-04-20	Mcneil-Ppc, Inc.	Pharmaceutical compositions and methods for treating the symptoms of overindulgence
WO1992015332A1 (en) *	1991-03-04	1992-09-17	Warner-Lambert Company	Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
DE4131678A1 (de)	1991-04-13	1992-10-15	Beiersdorf Ag	Stabile multiple emulsionen
ES2130152T3 (es)	1991-12-06	1999-07-01	Glaxo Group Ltd	Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
AU3247593A (en)	1991-12-20	1993-07-28	Warner-Lambert Company	Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
US5294433A (en) *	1992-04-15	1994-03-15	The Procter & Gamble Company	Use of H-2 antagonists for treatment of gingivitis
IT1256345B (it)	1992-08-20	1995-12-01		Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
WO1994007541A1 (en)	1992-09-29	1994-04-14	Merck & Co., Inc.	Ibuprofen-h2 antagonist combinations
IT1256450B (it)	1992-11-26	1995-12-05	Soldato Piero Del	Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
US5686105A (en) *	1993-10-19	1997-11-11	The Procter & Gamble Company	Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CH686761A5 (de) *	1993-05-27	1996-06-28	Sandoz Ag	Galenische Formulierungen.
SE9301830D0 (sv)	1993-05-28	1993-05-28	Ab Astra	New compounds
DK66493D0 (da)	1993-06-08	1993-06-08	Ferring A S	Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
SE9302396D0 (sv)	1993-07-09	1993-07-09	Ab Astra	A novel compound form
US6312704B1 (en) *	1993-09-30	2001-11-06	Gattefosse, S.A.	Orally administrable composition capable of providing enhanced bioavailability when ingested
FR2710535B1 (fr) *	1993-09-30	1995-11-24	Gattefosse Ets Sa	Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion.
US6054136A (en)	1993-09-30	2000-04-25	Gattefosse S.A.	Orally administrable composition capable of providing enhanced bioavailability when ingested
JP3775796B2 (ja) *	1993-10-06	2006-05-17	ニコックスエスエイ	抗炎症活性及び／又は鎮痛活性を有する硝酸エステル類及びそれらの製造方法
US5514663A (en)	1993-10-19	1996-05-07	The Procter & Gamble Company	Senna dosage form
WO1995011024A1 (en)	1993-10-19	1995-04-27	The Procter & Gamble Company	Picosulphate dosage form
US5643960A (en) *	1994-04-15	1997-07-01	Duke University	Method of delaying onset of alzheimer's disease symptoms
US6025395A (en) *	1994-04-15	2000-02-15	Duke University	Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
ATE184589T1 (de)	1994-05-10	1999-10-15	Nicox Sa	Nitroverbindingen und ihre zubereitungen mit entzündungsremmenden, schmertzlindernden und antithrombotischen wirkungen
WO1996001623A1 (en)	1994-07-08	1996-01-25	Astra Aktiebolag	Multiple unit tableted dosage form i
SE9500478D0 (sv)	1995-02-09	1995-02-09	Astra Ab	New pharmaceutical formulation and process
WO1996033697A1 (fr) *	1995-04-24	1996-10-31	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Formulation auto-emulsionnable formant une emulsion huile dans l'eau
US5955451A (en) *	1995-05-12	1999-09-21	The University Of Texas System Board Of Regents	Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
EP0760237A1 (en) *	1995-08-30	1997-03-05	Cipla Limited	Oil-in-water microemulsions
SE9600070D0 (sv)	1996-01-08	1996-01-08	Astra Ab	New oral pharmaceutical dosage forms
US6231888B1 (en)	1996-01-18	2001-05-15	Perio Products Ltd.	Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
WO1998022117A1 (en)	1996-11-22	1998-05-28	The Procter & Gamble Company	Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
SE510666C2 (sv)	1996-12-20	1999-06-14	Astra Ab	Nya Kristallmodifikationer
US6160020A (en) *	1996-12-20	2000-12-12	Mcneill-Ppc, Inc.	Alkali metal and alkaline-earth metal salts of acetaminophen
SE510643C2 (sv) *	1997-06-27	1999-06-14	Astra Ab	Termodynamiskt stabil omeprazol natrium form B
DK0989851T3 (da) *	1997-07-29	2003-01-27	Upjohn Co	Selvemulgerende formulering indeholdende sure lipofile forbindelser
CA2301883A1 (en)	1997-09-11	1999-03-18	Nycomed Danmark A/S	Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
US6395298B1 (en) *	1997-10-31	2002-05-28	Pharmacia Corporation	Gellan gum tablet coating
JP2002501897A (ja)	1998-01-30	2002-01-22	セプラコール，インク．	Ｒ−ランソプラゾール組成物及び方法
EP1056457A4 (en)	1998-01-30	2006-10-25	Sepracor Inc	S-LANSOPRAZOLE COMPOSITIONS AND METHODS OF USE
AU3843999A (en) *	1998-05-07	1999-11-23	Elan Corporation, Plc	Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
EP0984012A3 (en) *	1998-08-31	2001-01-10	Pfizer Products Inc.	Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
MXPA01003197A (es)	1998-09-28	2004-04-21	Warner Lambert Co	Suministro enterico y colonico utilizando capsulas de chpm.
US6485747B1 (en) *	1998-10-30	2002-11-26	Monsanto Company	Coated active tablet(s)
US6638522B1 (en) *	1998-12-11	2003-10-28	Pharmasolutions, Inc.	Microemulsion concentrate composition of cyclosporin
US6635281B2 (en) *	1998-12-23	2003-10-21	Alza Corporation	Gastric retaining oral liquid dosage form
US6267985B1 (en)	1999-06-30	2001-07-31	Lipocine Inc.	Clear oil-containing pharmaceutical compositions
AU3883700A (en)	1999-03-31	2000-10-16	Pharmacia & Upjohn Company	Pharmaceutical emulsions for retroviral protease inhibitors
WO2000071122A1 (en)	1999-05-20	2000-11-30	Par Pharmaceutical, Inc.	Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
TWI243672B (en) *	1999-06-01	2005-11-21	Astrazeneca Ab	New use of compounds as antibacterial agents
US6126816A (en) *	1999-07-14	2000-10-03	Ruiz, Jr.; Reuben F.	Wastewater treatment device
US20020102301A1 (en) *	2000-01-13	2002-08-01	Joseph Schwarz	Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
US6787164B2 (en)	2000-02-23	2004-09-07	Bioselect Innovations, Inc.	Composition and method for treating the effects of diseases and maladies
SE0000773D0 (sv) *	2000-03-08	2000-03-08	Astrazeneca Ab	New formulation
US20020044962A1 (en)	2000-06-06	2002-04-18	Cherukuri S. Rao	Encapsulation products for controlled or extended release
SE0002476D0 (sv)	2000-06-30	2000-06-30	Astrazeneca Ab	New compounds
US6544556B1 (en) *	2000-09-11	2003-04-08	Andrx Corporation	Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
US20020045184A1 (en)	2000-10-02	2002-04-18	Chih-Ming Chen	Packaging system
FR2818905A1 (fr) *	2000-12-28	2002-07-05	Cll Pharma	Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile
AR036354A1 (es)	2001-08-31	2004-09-01	Takeda Chemical Industries Ltd	Preparacion solida
US7467633B2 (en) *	2005-03-10	2008-12-23	Huntsman Petrochemical Corporation	Enhanced solubilization using extended chain surfactants

2000
- 2000-03-08 SE SE0000774A patent/SE0000774D0/xx unknown
2001
- 2001-02-26 AR ARP010100864A patent/AR027554A1/es not_active Application Discontinuation
- 2001-03-06 SK SK1258-2002A patent/SK285749B6/sk not_active IP Right Cessation
- 2001-03-06 MX MXPA02008658A patent/MXPA02008658A/es active IP Right Grant
- 2001-03-06 AU AU2001237875A patent/AU2001237875B2/en not_active Ceased
- 2001-03-06 CA CA002401857A patent/CA2401857A1/en not_active Abandoned
- 2001-03-06 US US10/221,079 patent/US7736666B2/en not_active Expired - Fee Related
- 2001-03-06 CN CNB018062938A patent/CN1283229C/zh not_active Expired - Fee Related
- 2001-03-06 CZ CZ20023006A patent/CZ303524B6/cs not_active IP Right Cessation
- 2001-03-06 AT AT01910304T patent/ATE311173T1/de active
- 2001-03-06 EE EEP200200483A patent/EE200200483A/xx unknown
- 2001-03-06 EP EP01910304A patent/EP1267831B1/en not_active Expired - Lifetime
- 2001-03-06 DK DK01910304T patent/DK1267831T3/da active
- 2001-03-06 JP JP2001564740A patent/JP4656479B2/ja not_active Expired - Fee Related
- 2001-03-06 WO PCT/SE2001/000466 patent/WO2001066087A1/en not_active Ceased
- 2001-03-06 SI SI200130487T patent/SI1267831T1/sl unknown
- 2001-03-06 KR KR1020027011733A patent/KR100771318B1/ko not_active Expired - Fee Related
- 2001-03-06 IL IL15138001A patent/IL151380A0/xx not_active IP Right Cessation
- 2001-03-06 DE DE60115402T patent/DE60115402T2/de not_active Expired - Lifetime
- 2001-03-06 HU HU0300539A patent/HU229103B1/hu not_active IP Right Cessation
- 2001-03-06 BR BRPI0109012-7A patent/BR0109012B1/pt not_active IP Right Cessation
- 2001-03-06 ES ES01910304T patent/ES2253354T3/es not_active Expired - Lifetime
- 2001-03-06 RU RU2002122745/15A patent/RU2275908C2/ru not_active IP Right Cessation
- 2001-03-06 AU AU3787501A patent/AU3787501A/xx active Pending
- 2001-03-07 MY MYPI20011044A patent/MY137749A/en unknown
- 2001-06-03 UA UA2002086882A patent/UA76098C2/uk unknown
2002
- 2002-09-03 IS IS6538A patent/IS6538A/is unknown
- 2002-09-03 NO NO20024194A patent/NO331921B1/no not_active IP Right Cessation
- 2002-09-04 ZA ZA200207109A patent/ZA200207109B/en unknown
2010
- 2010-04-28 US US12/768,820 patent/US20100266683A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BR0109012A (pt)	2003-06-03
SK12582002A3 (sk)	2003-04-01
JP2003525893A (ja)	2003-09-02
SI1267831T1 (sl)	2006-04-30
HUP0300539A3 (en)	2003-09-29
HK1053795A1 (en)	2003-11-07
RU2275908C2 (ru)	2006-05-10
DE60115402D1 (de)	2006-01-05
KR100771318B1 (ko)	2007-10-29
IL151380A0 (en)	2003-04-10
NO331921B1 (no)	2012-04-30
RU2002122745A (ru)	2004-03-20
ZA200207109B (en)	2003-12-04
CN1416336A (zh)	2003-05-07
WO2001066087A1 (en)	2001-09-13
AR027554A1 (es)	2003-04-02
IS6538A (is)	2002-09-03
AU3787501A (en)	2001-09-17
SE0000774D0 (sv)	2000-03-08
CA2401857A1 (en)	2001-09-13
AU2001237875B2 (en)	2005-05-12
MXPA02008658A (es)	2003-02-24
HU229103B1 (en)	2013-07-29
NO20024194L (no)	2002-09-03
ATE311173T1 (de)	2005-12-15
CZ20023006A3 (cs)	2003-02-12
ES2253354T3 (es)	2006-06-01
BR0109012B1 (pt)	2014-08-26
KR20030011788A (ko)	2003-02-11
DE60115402T2 (de)	2006-08-03
PL358617A1 (en)	2004-08-09
US20030077303A1 (en)	2003-04-24
HUP0300539A2 (hu)	2003-07-28
EE200200483A (et)	2004-02-16
EP1267831A1 (en)	2003-01-02
UA76098C2 (en)	2006-07-17
US7736666B2 (en)	2010-06-15
NO20024194D0 (no)	2002-09-03
JP4656479B2 (ja)	2011-03-23
US20100266683A1 (en)	2010-10-21
EP1267831B1 (en)	2005-11-30
CZ303524B6 (cs)	2012-11-14
MY137749A (en)	2009-03-31
SK285749B6 (sk)	2007-07-06
CN1283229C (zh)	2006-11-08

Publication	Publication Date	Title
DK1267831T3 (da)	2006-03-20	Hidtil ukendt selvemulgerende system til lægemiddelindgift
PT1267832E (pt)	2004-09-30	Sistema auto-emulsionante de libertacao de farmaco
KR870002835A (ko)	1987-04-13	이온화성 소수성약제의 약제학적 제조방법
ATE270544T1 (de)	2004-07-15	Halbfeste arzneizubereitung enthaltend isotretinoin
DK1320356T4 (da)	2011-09-12	Fremstilling af vitaminemulsioner og koncentrater deraf
MA28748B1 (fr)	2007-07-02	Applications galeniques de melanges auto-emulsionnants d'excipients lipidiques
SE0102993D0 (sv)	2001-09-07	New self emulsifying drug delivery system
FR2849992B1 (fr)	2007-03-16	Composition pour une administration par voie orale contenant des capsaicinoides
BR0112860A (pt)	2003-04-29	Dispositivo para coleta de lìquido seminal animal
NO20034139L (no)	2003-11-11	Faste oralt dispergerbare farmasöytiske formuleringer
DE60115466D1 (de)	2006-01-05	Wirkstoffvorläufer von imidazopyridin-derivaten
BRPI0513051A (pt)	2008-04-22	combinação de inibidores de transcriptase reversa e de protease anti-hiv
DK1268522T3 (da)	2009-01-12	LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler
ATE255407T1 (de)	2003-12-15	Pharmazeutische zusammensetzungen, die terbinafin enthalten
TH102356B (th)	2010-06-30	ระบบนำส่งยาแบบอีมัลซิฟายตัวเองชนิดใหม่
EA200600009A2 (ru)	2006-06-30	Фармацевтические композиции, содержащие активные соединения витамина d
TH102356A (th)	2010-06-30	ระบบนำส่งยาแบบอีมัลซิฟายตัวเองชนิดใหม่
TH100976A (th)	2010-04-23	ระบบนำส่งยาแบบอีมัลชิฟายตัวเองชนิดใหม่
DE60123419D1 (de)	2006-11-09	Flüssige arzneizubereitungen für die orale verabreichung von unangenehm, bitterschmeckenden arzneimitteln
ITRM20010731A1 (it)	2003-06-12	Procedimento per la produzione di emulsioni acquose stabili di sostanze lipofile di interesse farmaceutico ed emulsioni cosi' ottenute.
TH77896A (th)	2006-06-05	สารประกอบชนิดใหม่